Skip to main content
. 2022 Mar 3;11(5):1387. doi: 10.3390/jcm11051387

Table 7.

Adverse clinical events.

Parameters Colchicine
(n = 50)
Placebo
(n = 51)
OR 95% Cl p
Nausea, n (%) 6 (12) 5 (9.8) 1.255 0.357–4.408 0.755
Vomiting, n (%) 1 (2) 2 (3.9) 0.500 0.044–5.696 1.000
Lack of appetite, n (%) 11 (22) 14 (27.5) 0.745 0.3–1.85 0.605
Diarrhea, n (%) 16 (32) 6 (11.8) 3.529 1.249–9.972 0.010
Abdominal pain, n (%) 6 (12) 2 (3.9) 3.341 0.641–17.419 0.151
Convulsions, n (%) 1 (2) 4 (7.8) 0.24 0.026–2.225 0.363
Tingling in the extremities, n (%) 5 (10) 7 (13.7) 0.698 0.206–2.367 0.761
Skin rashes, n (%) 0 (0) 0 (0)